Clinical trial
Donepezil Double Blind Trial for ECT Memory Disfunction
NCT00465283 · BeerYaakov Mental Health Center, Other · Unknown status
Key facts
| NCT number | NCT00465283 |
|---|---|
| Title | Donepezil Double Blind Trial for ECT Memory Disfunction |
| Official title | Donepezil Double Blind Trial for ECT Memory Disfunction |
| Lead sponsor | BeerYaakov Mental Health Center, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder |
| Intervention type | Drug |
| Interventions | Donepezil |
| Enrollment | 40 |
| Start date | May 1, 2007 |
| Primary completion | Jan 1, 2010 |
| Completion | Jan 1, 2010 |
| First posted | Apr 24, 2007 |
| Last update posted | Jan 27, 2009 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: